Compound ID | 678

VRC4887

Synonym(s): NVD PDF 386

Class: Peptide deformylase inhibitor

Spectrum of activity: Gram-negative
Details of activity: Growth inhibitor; active against CAP
Institute where first reported: Vernalis, UK; Novartis, Switzerland; Pfizer, US
Year first mentioned: 2000
Highest developmental phase: Phase 1
Development status: Inactive
Reason Dropped: Toxicity issues (JS) and possible resistance issues

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.